Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Clinical trials Accrued Clinical Trials Fee, Current Accrued Clinical Trials Fee, Current Schedule Of Shares Reserved For Future Issuance Schedule Of Shares Reserved For Future Issuance [Table Text Block] Schedule Of Shares Reserved For Future Issuance Title of 12(b) Security Title of 12(b) Security Number of renewal options Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options Subsequent Event Subsequent Event [Member] Document Fiscal Year Focus Document Fiscal Year Focus Adjustment to Compensation, Amount Adjustment to Compensation Amount Additional advance paid Additional Advance Paid Additional Advance Paid Financial Instrument [Axis] Financial Instrument [Axis] Segment Reporting [Abstract] No conversion or exchange, required payment as percentage of as outstanding principal and accrued and unpaid interest Debt Instrument, Convertible, No Conversion Or Exchange, Required Payment, Percent Of Interest Debt Instrument, Convertible, No Conversion Or Exchange, Required Payment, Percent Of Interest Common stock, $0.0001 par value; 500,000,000 shares authorized as of both June 30, 2026 and December 31, 2025; 31,144,754 and 30,879,355 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Number of votes per common stock Number Of Votes Per Common Share Number Of Votes Per Common Share 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Taxes paid related to net settlement of stock awards Payment, Tax Withholding, Share-Based Payment Arrangement Valuation Approach Technique, Probability-Weighted Expected Return Method Valuation Approach Technique, Probability-Weighted Expected Return Method [Member] Valuation Approach Technique, Scenario Based Method Employee-related expenses Employee-related Liabilities, Current Entity Ex Transition Period Entity Ex Transition Period Restatement Determination Date Restatement Determination Date Derivative Instrument [Axis] Derivative Instrument [Axis] Issuance of common stock for vesting of restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Class of warrant or right, number of securities called by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Amendment Flag Amendment Flag CURRENT LIABILITIES Liabilities, Current [Abstract] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Contingent Value Rights Agreement Contingent Value Rights Agreement [Member] Contingent Value Rights Agreement Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Leases [Abstract] GeneFab Transaction Related Parties Related Party Transactions Disclosure [Text Block] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Entity Address, State or Province Entity Address, State or Province Computer equipment and software Computer Equipment and Software [Member] Computer Equipment and Software PEO Total Compensation Amount PEO Total Compensation Amount Term of agreement (in years) Research and Development Expense, Term of Agreement Research and Development Expense, Term of Agreement Common stock, par or stated value (in dollars per share) Common Stock, Par or Stated Value Per Share BlueRock BlueRock [Member] BlueRock Cash and Cash Equivalents [Abstract] Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Weighted-average number of shares used in computing net loss per share, basic (in shares) Weighted-average shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current 2030 Lessee, Operating Lease, Liability, to be Paid, Year Four Decrease in operating lease right-of-use assets resulting from lease remeasurement Increase (Decrease) In Operating Lease, Right-Of-Use Assets, Remeasurement Increase (Decrease) In Operating Lease, Right-Of-Use Assets, Remeasurement Deferred revenue - related party Increase (Decrease) in Deferred Revenue Other non-current liabilities Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net Entity Address, City or Town Entity Address, City or Town Original grant amount multiplier Government Assistance, Transaction Duration, Royalty Payment Threshold, Original Grant Amount Multiplier Government Assistance, Transaction Duration, Royalty Payment Threshold, Original Grant Amount Multiplier Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Class of Stock [Axis] Class of Stock [Axis] Basis of Presentation and Principles of Consolidation Basis of Accounting, Policy [Policy Text Block] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount GeneFab sublease income - related party Total sublease income Sublease income Sublease Income Other income: Nonoperating Income (Expense) [Abstract] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] 2029 Lessor, Operating Lease, Payment to be Received, Year Three Milestone payments, aggregate payment cap Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments Subsequent Event Type [Axis] Subsequent Event Type [Axis] Capital contribution from related party Adjustments to Additional Paid in Capital, Other Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Contingent Value Rights Agreement, Milestone One Contingent Value Rights Agreement, Milestone One [Member] Contingent Value Rights Agreement, Milestone One Recent Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Segment Reporting Information, by Segment Segment Reporting [Table Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Related Party [Axis] Related and Nonrelated Parties [Axis] Prepayment credit Lessor, Operating Lease, Payment to be Received, Prepayment Credit Lessor, Operating Lease, Payment to be Received, Prepayment Credit Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Schedule of Maturities of Lease Liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Conversion price (in dollars per share) Temporary Equity, Redemption Price Per Share Document Period End Date Document Period End Date Net cash provided by (used in) investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Costs Incurred On Behalf Of GeneFab Costs Incurred On Behalf Of GeneFab [Member] Costs Incurred On Behalf Of GeneFab Option, maximum purchase amount (in shares) Option Indexed to Issuer's Equity, Shares Principal amount of unsecured convertible promissory note Aggregate principal amount Debt Instrument, Face Amount 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Stockholders’ Equity Equity [Text Block] Beginning balance (in shares) Ending balance (in shares) Series A redeemable convertible preferred stock, outstanding (in shares) Temporary Equity, Shares Outstanding Security Exchange Name Security Exchange Name Senti Biosciences, Inc. Senti Biosciences, Inc. [Member] Senti Biosciences, Inc. Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Total liabilities measured at fair value Liabilities, Fair Value Disclosure Entity Shell Company Entity Shell Company Gain from change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Authorized for issuance under share-based payment arrangement (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Operating lease liabilities, current Operating Lease, Liability, Current Cash and Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Schedule of Property and Equipment, Net Property, Plant, and Equipment [Table Text Block] Net Loss Per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Earnings Per Share [Abstract] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Award amount Government Assistance, Award Amount TOTAL LIABILITIES Liabilities Trading Symbol Trading Symbol Shares issued upon conversion Convertible Preferred Stock, Shares Issued upon Conversion Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Option, exercise price (in dollars per share) Option Indexed to Issuer's Equity, Strike Price Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Company Selected Measure Name Company Selected Measure Name Sale of Stock [Domain] Sale of Stock [Domain] Schedule of Restrictions on Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Income Tax Disclosure [Abstract] California Institute of Regenerative Medicine (“CIRM”) California Institute of Regenerative Medicine (“CIRM”) [Member] California Institute of Regenerative Medicine (“CIRM”) Expected costs and expenses incurred Research and Development Arrangement, Expected Costs Research and Development Arrangement, Expected Costs SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION: Noncash Investing and Financing Items [Abstract] Gain on lease modification Remaining amount Gain (Loss) On Lease Modification, Gross Gain (Loss) On Lease Modification, Gross Credit Facility [Domain] Credit Facility [Domain] Schedule of Cash, Cash Equivalents and Investments Cash, Cash Equivalent, and Investment [Table Text Block] Related Party Transactions [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Other Other Sundry Liabilities, Noncurrent Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Warrants to purchase common stock issued in connection with Series A redeemable convertible preferred stock Warrants to purchase common stock issued in connection with Series A redeemable convertible preferred stock Warrant [Member] Weighted-average number of shares used in computing net loss per share, diluted (in shares) Weighted-average shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Government assistance, royalty and licensing expense, percentage of revenue (in percent) Government Assistance, Royalty And Licensing Expense, Percentage Of Revenue Government Assistance, Royalty And Licensing Expense, Percentage Of Revenue Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Schedule of Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Shareholders Shareholders [Member] Shareholders Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Reportable Segment Reportable Segment [Member] Reportable Segment Award Timing Predetermined Award Timing Predetermined [Flag] Letters of credit Letters of Credit Outstanding, Amount Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Other income (expense), net Other Nonoperating Expense Level 1 Fair Value, Inputs, Level 1 [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Total undiscounted lease payments Lessee, Operating Lease, Liability, to be Paid 2025 ATM Agreement 2025 ATM Agreement [Member] 2025 ATM Agreement Cash acquired through reverse recapitalization Cash Acquired Through Reverse Recapitalization Cash Acquired Through Reverse Recapitalization All Executive Categories All Executive Categories [Member] Common stock reserved for issuance upon exchange of the Initial Notes Common Stock Reserved [Member] Common Stock Reserved Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Operating lease liabilities Increase (Decrease) in Operating Lease Liability BKPBIOTECH, Inc. and JLSA2 Therapeutics, Inc. BKPBIOTECH, Inc. and JLSA2 Therapeutics, Inc. [Member] BKPBIOTECH, Inc. and JLSA2 Therapeutics, Inc. Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Preferred stock, par value per share (in dollars per share) Preferred Stock, Par or Stated Value Per Share Depreciation Depreciation Plan Name [Domain] Plan Name [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Aggregate offering price Sale of Stock, Consideration Receivable on Transaction Sale of Stock, Consideration Receivable on Transaction Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Probability of liquidation scenario Measurement Input, Probability of Liquidation Scenario [Member] Measurement Input, Probability of Liquidation Scenario Lease renewal term (in years) Lessee, Operating Lease, Renewal Term Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Fair Value Disclosures [Abstract] Debt Disclosure [Abstract] Government assistance, repayment (in percent) Government Assistance, Repayment, Percent Government Assistance, Repayment, Percent Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Segment Reporting Segment Reporting [Text Block] Minimum Minimum [Member] Operating lease right-of-use assets Increase (Decrease) in Operating Lease, Right-Of-Use Asset Increase (Decrease) in Operating Lease, Right-Of-Use Asset Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Abstract] Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Abstract] Expiration Date Trading Arrangement Expiration Date Vesting of early exercise of common stock options Stock Issued During Period, Value, Vesting Of Early Exercise Of Stock Options Stock Issued During Period, Value, Vesting Of Early Exercise Of Stock Options Location, Statement of Income, Balance [Axis] Location, Statement of Income, Balance [Axis] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Threshold days for repayment Government Assistance, Loan Conversion Option, Threshold Days For Repayment Government Assistance, Loan Conversion Option, Threshold Days For Repayment Nonrelated Party Nonrelated Party [Member] Convertible notes - related party Convertible Debt, Fair Value Disclosures Government assistance, repayment, interest rate (in percent) Government Assistance, Repayment, Interest Rate, Percent Government Assistance, Repayment, Interest Rate, Percent Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Thereafter Lessor, Operating Lease, Payment to be Received, after Year Five Proceeds from issuance of common stock related to ATM, net of commissions Proceeds from Issuance of Common Stock Common stock, authorized (in shares) Common Stock, Shares Authorized Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Probability of merger scenario Measurement Input, Probability of Probability of Merger Scenario [Member] Measurement Input, Probability of Probability of Merger Scenario Number of shares issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Exercise Price Award Exercise Price Senior Secured Convertible Notes, Additional Funding Senior Secured Convertible Notes, Additional Funding [Member] Senior Secured Convertible Notes, Additional Funding CASH FLOWS FROM INVESTING ACTIVITIES Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Related Party Transaction [Axis] Related Party Transaction [Axis] Segment Reporting [Line Items] Segment Reporting [Line Items] Document Quarterly Report Document Quarterly Report 2027 Lessor, Operating Lease, Payment to be Received, Year One Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments [Domain] Segments [Domain] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Securities Purchase Agreement and the Notes Debt Disclosure [Text Block] Restricted Cash and Cash Equivalents [Axis] Restricted Cash and Cash Equivalents [Axis] Issuance costs Debt Issuance Costs, Net Back rent payment Lessor, Operating Lease, Payment to be Received, Back Rent Payment Lessor, Operating Lease, Payment to be Received, Back Rent Payment Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Lease Contractual Term [Axis] Lease Contractual Term [Axis] Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Measurement Input Type [Domain] Measurement Input Type [Domain] Government Assistance, Type [Axis] Government Assistance, Type [Axis] New Enterprise Associates, Inc. (“NEA”) New Enterprise Associates, Inc. (“NEA”) [Member] New Enterprise Associates, Inc. (“NEA”) Aggregate purchase price Sale of Stock, Consideration Received on Transaction Adoption Date Trading Arrangement Adoption Date Net proceeds Proceeds from Issuance or Sale of Equity Cash dividends declared and paid, common stock Dividends, Common Stock, Cash Counterparty Name [Domain] Counterparty Name [Domain] TOTAL STOCKHOLDERS’ EQUITY (DEFICIT) Beginning balance Ending balance Equity, Attributable to Parent Total other income Nonoperating Income (Expense) ASSETS Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Maximum aggregate offering price Sale of Stock, Consideration To Be Received On Transaction Sale of Stock, Consideration To Be Received On Transaction Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Fee amount Debt Instrument, Fee Amount Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Total lease liabilities Operating Lease, Liability Payment of issuance costs Payment of issuance costs Payments of Stock Issuance Costs Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Private Placement Private Placement [Member] Facilities and other Facilities And Other [Member] Facilities And Other Interest income Interest Income (Expense), Nonoperating Letter of Credit Letter of Credit [Member] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Number of operating segments Number of Operating Segments Total Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Restricted stock units outstanding Restricted Stock Units (RSUs) [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Entity Central Index Key Entity Central Index Key Less: accumulated depreciation Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization All Adjustments to Compensation All Adjustments to Compensation [Member] Other non-cash charges Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Other Item Equity [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Shares issuable (in dollars per share) Shares Issuable. Price Per Share Shares Issuable. Price Per Share Warrants, number of securities callable by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Callable by Warrants or Rights Class of Warrant or Right, Number of Securities Callable by Warrants or Rights Professional and other service fees Accrued Professional Fees, Other, Current Accrued Professional Fees, Other, Current Income Statement [Abstract] STOCKHOLDERS’ EQUITY (DEFICIT) Equity, Attributable to Parent [Abstract] Document Transition Report Document Transition Report Ownership [Axis] Ownership [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Operating expenses: Operating Expenses [Abstract] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Additional advance payment commitment Additional Advance Payment Commitment Additional Advance Payment Commitment City Area Code City Area Code Government assistance, royalty and licensing expense, per funding received Government Assistance, Royalty And Licensing Expense, Per Funding Received Government Assistance, Royalty And Licensing Expense, Per Funding Received All Individuals All Individuals [Member] Subsequent Events Subsequent Events [Text Block] Name Forgone Recovery, Individual Name Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Termination fee payable Sale Of Stock, Termination Fee Payable Sale Of Stock, Termination Fee Payable Statement [Line Items] Statement [Line Items] TOTAL ASSETS Assets Entity [Domain] Entity [Domain] Lessee, Operating Lease, Liability, Payment, Due [Abstract] Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Alameda Alameda [Member] Alameda Warrant exercises, allowable change in threshold percentage Class of Warrant or Right, Exercisable, Allowable Change In Threshold Percentage Class of Warrant or Right, Exercisable, Allowable Change In Threshold Percentage Common stock reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Convertible notes - related party Convertible Debt [Member] Convertible notes - related party Convertible Debt, Current Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Stock-based Compensation Share-Based Payment Arrangement [Text Block] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Proceeds from issuance of convertible notes - related party Proceeds from Convertible Debt Issuance of common stock related to ATM, net of commissions and issuance costs (in shares) Stock Issued During Period, Shares, New Issues Accrued expenses and other current liabilities Total accrued expenses and other current liabilities Accounts Payable and Other Accrued Liabilities, Current PEO PEO [Member] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Total stock-based compensation Share-Based Payment Arrangement, Expense Other non-current liabilities Total other non-current liabilities Other Liabilities, Noncurrent Number of additional shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount GeneFab sublease deferred income - related party Increase (Decrease) In Deferred Sublease Income Increase (Decrease) In Deferred Sublease Income Warrant exercises, stockholder approval threshold (in percent) Class of Warrant or Right, Exercisable, Stockholder Approval, Threshold Percentage Class of Warrant or Right, Exercisable, Stockholder Approval, Threshold Percentage Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Current income tax liability Taxes Payable, Current Accumulated Deficit Retained Earnings [Member] Operating lease liabilities, non-current Operating Lease, Liability, Noncurrent Total operating expenses Operating Expenses Money market funds Money Market Funds [Member] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Schedule of Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Net loss per share, diluted (in dollars per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Sublease income - variable Operating Lease, Variable Lease Income Net settlement of restricted stock units for employee taxes Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Warrant exercises, allowable change in threshold percentage, prior notice term (in days) Class of Warrant or Right, Exercisable, Allowable Change In Threshold Percentage, Prior Notice Term Class of Warrant or Right, Exercisable, Allowable Change In Threshold Percentage, Prior Notice Term Sale of stock commission percentage on gross sales Sale Of Stock, Commission As Percentage Of Gross Proceeds Sale Of Stock, Commission As Percentage Of Gross Proceeds Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table] Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table] Ownership [Domain] Ownership [Domain] Research and development (including related party costs of $3,516 and $3,586 for the three months ended June 30, 2026 and 2025, respectively, and $3,798 and $7,656 for the six months ended June 30, 2026 and 2025, respectively) Research and development Research and Development Expense Lease Contractual Term [Domain] Lease Contractual Term [Domain] Share-Based Payment Arrangement [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Collaboration revenue - related party Revenue from Contract with Customer, Excluding Assessed Tax Property and equipment, net Property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Advance payment, remaining amount Additional Advance Payment Commitment, Remaining Amount Additional Advance Payment Commitment, Remaining Amount Financial Instruments [Domain] Financial Instruments [Domain] GeneFab GeneFab [Member] GeneFab Maturity date extension, threshold business days Debt Instrument, Convertible, Maturity Date Extension, Threshold Days Debt Instrument, Convertible, Maturity Date Extension, Threshold Days Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Liabilities associated with CIRM Grant Government Assistance, Liability, Noncurrent Prepaid expenses Prepaid Expense, Current Option, maximum worth Option Indexed to Issuer's Equity, Shares, Value Option Indexed to Issuer's Equity, Shares, Value Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Sublease payments reduction fee Lessor, Operating Lease, Sublease Payments Lessor, Operating Lease, Sublease Payments Segment Reporting [Table] Segment Reporting [Table] Related Party Transaction [Table] Related Party Transaction [Table] Certain Investor Certain Investor [Member] Certain Investor Sale of Stock [Axis] Sale of Stock [Axis] Schedule of Lease Cost Lease, Cost [Table Text Block] Other Other Assets, Current Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Initial recognition at fair value at May 20, 2026 Fair value at June 30, 2026 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Loss from operations Operating Income (Loss) Consideration received in collaborative development agreement Revenue, Remaining Performance Obligation, Amount Current Fiscal Year End Date Current Fiscal Year End Date Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Related Party Transaction [Domain] Related Party Transaction [Domain] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Equity Option Equity Option [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Restricted Cash and Cash Equivalent Item [Line Items] Restricted Cash and Cash Equivalent Item [Line Items] Common stock, issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Organization and Description of Business Business Description and Basis of Presentation [Text Block] Number of shares issuable in transaction (in shares) Sale of Stock, Number of Shares Issuable in Transaction Sale of Stock, Number of Shares Issuable in Transaction Conversion of Series A redeemable convertible preferred stock to common stock Temporary Equity, Conversion of Stock, Amount Converted Temporary Equity, Conversion of Stock, Amount Converted Equity Components [Axis] Equity Components [Axis] Accounts receivable Increase (Decrease) in Accounts Receivable Product and Service [Domain] Product and Service [Domain] Related Party Related Party [Member] Class of Stock [Line Items] Class of Stock [Line Items] 2022 Equity Incentive Plan ( the “2022 EIP”) 2022 Equity Incentive Plan ( the “2022 EIP”) [Member] 2022 Equity Incentive Plan ( the “2022 EIP”) Entity Interactive Data Current Entity Interactive Data Current Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Small Business Entity Small Business Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Termination Date Trading Arrangement Termination Date Net settlement of restricted stock units for employee taxes (shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Property, Plant, and Equipment [Line Items] Property, Plant, and Equipment [Line Items] GeneFab sublease deferred income - related party Deferred Sublease Income Deferred Sublease Income Subsequent Events [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Senior Secured Convertible Notes Senior Secured Convertible Notes [Member] Senior Secured Convertible Notes Grant Grant [Member] Deposits Deposits Assets, Current Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Sublease income to be earned Lessor, Operating Lease, Sublease Payments To Be Received Lessor, Operating Lease, Sublease Payments To Be Received MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Other non-current assets Other Assets, Noncurrent Occurrence of default, annual interest accrual rate (in percent) Debt Instrument, Convertible Default, Interest Rate Debt Instrument, Convertible Default, Interest Rate Document Type Document Type Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value as of Grant Date Award Grant Date Fair Value Operating cash flows used for operating leases Operating Lease, Proceeds (Payments) Operating Lease, Proceeds (Payments) Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Arrangement Duration Trading Arrangement Duration Subsequent Event [Line Items] Subsequent Event [Line Items] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Other Financial Statement information Additional Financial Information Disclosure [Text Block] Series A redeemable convertible preferred stock, authorized (in shares) Temporary Equity, Shares Authorized Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Restrictions on Cash and Cash Equivalents [Table] Restrictions on Cash and Cash Equivalents [Table] Changes in operating assets and liabilities: Increase (Decrease) in Operating Assets [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Commitments and contingencies (Note 14) Commitments and Contingencies Schedule of Other Noncurrent Liabilities Other Noncurrent Liabilities [Table Text Block] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Property and equipment at cost Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Government assistance, co-funding obligation, amount Government Assistance, Co-Funding Obligation, Amount Government Assistance, Co-Funding Obligation, Amount Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Furniture and fixtures Furniture and Fixtures [Member] Counterparty Name [Axis] Counterparty Name [Axis] LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) Liabilities and Equity [Abstract] Beginning balance Ending balance Temporary Equity, Carrying Amount, Attributable to Parent 2030 Lessor, Operating Lease, Payment to be Received, Year Four Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Award Type [Domain] Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount 2026, for the remainder of the year Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Fair Value Measurements Fair Value Disclosures [Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] Convertible past due rent Lessor, Operating Lease, Payment to be Received, Convertible Amount Lessor, Operating Lease, Payment to be Received, Convertible Amount Operating lease, term of contract (in years) Lessee, Operating Lease, Term of Contract Ownership percentage (in percent) Subsidiary, Ownership Percentage, Noncontrolling Owner PEO Name PEO Name Vesting of early exercise of common stock options (in shares) Stock Issued During Period, Shares, Vesting Of Early Exercise Of Stock Options Stock Issued During Period, Shares, Vesting Of Early Exercise Of Stock Options Leasehold improvements Leasehold Improvements [Member] Restricted cash Restricted cash Restricted Cash Total undiscounted sublease payments Total undiscounted sublease payments Lessor, Operating Lease, Payment to be Received Upfront payment under research collaboration and license agreement Contract with Customer, Liability Long-Lived Asset, Class [Axis] Long-Lived Asset, Class [Axis] Concentration of Credit Risk And Concentration of Business Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Legal Entity [Axis] Legal Entity [Axis] Liability Class [Axis] Liability Class [Axis] Common stock shares available for future issuance under equity plans Common Stock Under Equity Plans [Member] Common Stock Under Equity Plans Corporate Headquarters Corporate Headquarters [Member] Corporate Headquarters Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] CASH, CASH EQUIVALENTS, AND RESTRICTED CASH — Beginning of period CASH, CASH EQUIVALENTS, AND RESTRICTED CASH — End of period Total Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Celadon Partners SPV 24 (“Celadon”) Celadon Partners SPV 24 (“Celadon”) [Member] Celadon Partners SPV 24 (“Celadon”) Sublease income - base rent Operating Lease, Lease Income, Lease Payments Accounts payable Increase (Decrease) in Accounts Payable Other current liabilities Other Accrued Liabilities, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Senior Secured Convertible Notes, Tranche One Senior Secured Convertible Notes, Tranche One [Member] Senior Secured Convertible Notes, Tranche One Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Debt Instrument [Axis] Debt Instrument [Axis] Subsequent Event [Table] Subsequent Event [Table] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Total lease cost Lease, Cost Conversion of Series A convertible preferred stock to common stock (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Common stock shares available for future issuance under the 2022 Employee Stock Purchase Plan (the “ESPP”) 2022 Employee Stock Purchase Plan (the “2022 ESPP”) Employee Stock [Member] Operating Leases Lessee, Operating Leases [Text Block] Capital contribution from related party upon initial recognition of convertible notes at fair value - related party Capital Contribution Upon Initial Recognition Of Convertible Notes Capital Contribution Upon Initial Recognition Of Convertible Notes Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Net loss per share, basic (in dollars per share) Earnings Per Share, Basic Milestone expiration term Collaborative Arrangement, Rights and Obligations, Milestone Expiration Term Collaborative Arrangement, Rights and Obligations, Milestone Expiration Term Measurement Input Type [Axis] Measurement Input Type [Axis] Deferred revenue - related party Deferred revenue, current - related party Contract with Customer, Liability, Current Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Award Type [Axis] Award Type [Axis] Short-term lease cost Short-Term Lease, Cost 2026, for the remainder of the year Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year Number of seats on the board of directors Number of Seats On The Board Of Directors Number of Seats On The Board Of Directors Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Accumulated deficit Retained earnings (accumulated deficit) Retained Earnings (Accumulated Deficit) Milestone payment, threshold net sales Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Threshold Net Sales Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Threshold Net Sales Product and Service [Axis] Product and Service [Axis] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Merger Agreement Merger Agreement [Member] Merger Agreement Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common Stock Common Stock [Member] Money market funds Debt Securities, Available-for-Sale Schedule of Sublease Income Operating Lease, Lease Income [Table Text Block] Operating lease cost Operating Lease, Cost Conversion of Series A convertible preferred stock to common stock (in shares) Temporary Equity, Conversion of Stock, Shares Converted Temporary Equity, Conversion of Stock, Shares Converted Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Cover [Abstract] Reduction of certain operating expenses Gain (Loss) On Lease Modification, Operating Expenses Gain (Loss) On Lease Modification, Operating Expenses Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Senior Secured Convertible Notes, Additional Funding, Obligation Senior Secured Convertible Notes, Additional Funding, Obligation [Member] Senior Secured Convertible Notes, Additional Funding, Obligation Derivative Contract [Domain] Derivative Contract [Domain] Depreciation and amortization Cost, Depreciation, Amortization and Depletion Unpaid issuance costs Stock Issuance Costs Incurred But Not Paid Stock Issuance Costs Incurred But Not Paid Equity Awards Adjustments Equity Awards Adjustments [Member] TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) Liabilities and Equity Variable lease cost Variable Lease, Cost Stock options issued and outstanding Stock options issued and outstanding Share-Based Payment Arrangement, Option [Member] Issuable upon conversion (in shares) Preferred Stock, Convertible, Shares Issuable Schedule of Maturities of Sublease Payments Lessor, Operating Lease, Payment to be Received, Maturity [Table Text Block] Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Plan Name [Axis] Plan Name [Axis] Related Party [Domain] Related and Nonrelated Parties [Domain] Tabular List, Table Tabular List [Table Text Block] Additional paid-in capital Additional Paid in Capital Rentable area Net Rentable Area Other income, net Other income, net Other Nonoperating Income (Expense) Bayer Bayer [Member] Bayer Decrease in operating lease liabilities resulting from lease remeasurement Decrease in operating lease liabilities resulting from lease remeasurement Increase (Decrease) In Operating Lease Liability, Remeasurement Increase (Decrease) In Operating Lease Liability, Remeasurement Number of business activities Number of Business Activities Number of Business Activities Schedule of Accrued Expenses and Other Current Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Name Awards Close in Time to MNPI Disclosures, Individual Name Grant transaction duration (in years) Government Assistance, Transaction Duration Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] 2022 Inducement Plan (the “2022 IN”) 2022 Inducement Plan (the “2022 IN”) [Member] 2022 Inducement Plan (the “2022 IN”) General and administrative General and Administrative Expense Long-Lived Asset, Class [Domain] Long-Lived Asset, Class [Domain] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Price per share (in dollars per share) Sale of Stock, Price Per Share Conversion of Series A redeemable convertible preferred stock to common stock Stock Issued During Period, Value, Conversion of Convertible Securities Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Table] Convertible debt, measurement input Debt Instrument, Measurement Input Adjustment to Compensation: Adjustment to Compensation [Axis] Celadon Partners, LLC Celadon Partners, LLC [Member] Celadon Partners, LLC Class of Stock [Domain] Class of Stock [Domain] Ownership percentage, as-converted basis (in percent) Subsidiary, Ownership Percentage, Noncontrolling Owner, As-Converted Basis Subsidiary, Ownership Percentage, Noncontrolling Owner, As-Converted Basis Stockholder approval, percentage of common stock outstanding Debt Instrument, Convertible, Stockholder Approval, Percentage Of Common Stock Outstanding Debt Instrument, Convertible, Stockholder Approval, Percentage Of Common Stock Outstanding Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Statement of Cash Flows [Abstract] Credit Facility [Axis] Credit Facility [Axis] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Total assets measured at fair value Assets, Fair Value Disclosure Warrant exercise term, on or prior to original issuance date anniversary (in years) Class of Warrant or Right, Exercisable, On Or Prior To Original Issuance Date Anniversary, Term Class of Warrant or Right, Exercisable, On Or Prior To Original Issuance Date Anniversary, Term Name Measure Name External services and supplies External Services And Supplies [Member] External Services And Supplies Income Tax Income Tax Disclosure [Text Block] Cash and Cash Equivalent [Table] Cash and Cash Equivalent [Table] CPIF II-7 Limited CPIF II-7 Limited [Member] CPIF II-7 Limited Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Convertible note issuance costs included in net loss - related party Convertible Debt Issuance Costs Included In Earnings Convertible Debt Issuance Costs Included In Earnings 2031 Lessee, Operating Lease, Liability, to be Paid, Year Five Debt Instrument [Line Items] Debt Instrument [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Additional Paid-in Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category 2031 Lessor, Operating Lease, Payment to be Received, Year Five Name Trading Arrangement, Individual Name Gain on lease modification Gain on lease modification Gain (Loss) On Lease Modification Gain (Loss) On Lease Modification Cash and cash equivalents Cash and Cash Equivalent Related And Nonrelated Parties Related And Nonrelated Parties [Member] Related And Nonrelated Parties Company Selected Measure Amount Company Selected Measure Amount Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents Disclosure [Text Block] Stock, Class of Stock [Table] Stock, Class of Stock [Table] CURRENT ASSETS Assets, Current [Abstract] Weighted-average remaining lease term (years) Operating Lease, Weighted Average Remaining Lease Term Government Assistance, Type [Domain] Government Assistance, Type [Domain] Derivative liability Derivative Liability Non-PEO NEO Non-PEO NEO [Member] Lab equipment Laboratory Equipment [Member] Laboratory Equipment Entity Address, Address Line One Entity Address, Address Line One Senior Secured Convertible Notes, Tranche Two Senior Secured Convertible Notes, Tranche Two [Member] Senior Secured Convertible Notes, Tranche Two Income tax provision (benefit) Income Tax Expense (Benefit) Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Award Timing Method Award Timing Method [Text Block] NET DECREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Contingent Value Rights Agreement, Milestone Three Contingent Value Rights Agreement, Milestone Three [Member] Contingent Value Rights Agreement, Milestone Three 2028 Lessor, Operating Lease, Payment to be Received, Year Two Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Probability of conversion scenario Measurement Input, Probability of Conversion Scenario [Member] Measurement Input, Probability of Conversion Scenario Proceeds from sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment Statement [Table] Statement [Table] Redeemable Convertible Preferred Stock [Member] Redeemable Convertible Preferred Stock [Member] Restatement Determination Date: Restatement Determination Date [Axis] Proceeds from CIRM Grant Proceeds from Stock Options Exercised Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Interest income Investment Income, Interest Personnel-related expenses, including stock-based compensation Personnel Related Expenses [Member] Personnel Related Expenses Net loss Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Warrant exercises, beneficial ownership threshold (in percent) Class of Warrant or Right, Exercisable, Beneficial Ownership, Threshold Percentage Class of Warrant or Right, Exercisable, Beneficial Ownership, Threshold Percentage Change in fair value of convertible notes - related party Gain on change in fair value of convertible notes - related party Fair Value, Option, Changes in Fair Value, Gain (Loss) GeneFab Option GeneFab Option GeneFab Option [Member] GeneFab Option Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Contingent Value Rights Agreement, Milestone Two Contingent Value Rights Agreement, Milestone Two [Member] Contingent Value Rights Agreement, Milestone Two Numerator: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]